Journal
NATURE
Volume 460, Issue 7259, Pages 1127-1131Publisher
NATURE PORTFOLIO
DOI: 10.1038/nature08248
Keywords
-
Categories
Funding
- Picower Foundation
- G. Harold and Leila Y. Mathers Charitable Foundation
- Lookout Fund [MH082070]
- California Institute for Regenerative Medicine (CIRM).
- Plan Estabilizacion Grupos SNS ENCYT 2015 [EMER07/56]
- Marie Curie program [IRG-FP7-PEOPLE-2007]
- National Institutes of Health (NIH) [GM069985, NS048187, GM082970]
- Howard Hughes Medical Institute
Ask authors/readers for more resources
Long interspersed element 1 (LINE-1 or L1) retrotransposons have markedly affected the human genome. L1s must retrotranspose in the germ line or during early development to ensure their evolutionary success, yet the extent to which this process affects somatic cells is poorly understood. We previously demonstrated that engineered human L1s can retrotranspose in adult rat hippocampus progenitor cells in vitro and in the mouse brain in vivo(1). Here we demonstrate that neural progenitor cells isolated from human fetal brain and derived from human embryonic stem cells support the retrotransposition of engineered human L1s in vitro. Furthermore, we developed a quantitative multiplex polymerase chain reaction that detected an increase in the copy number of endogenous L1s in the hippocampus, and in several regions of adult human brains, when compared to the copy number of endogenous L1s in heart or liver genomic DNAs from the same donor. These data suggest that de novo L1 retrotransposition events may occur in the human brain and, in principle, have the potential to contribute to individual somatic mosaicism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available